Clinical Trial Update: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares 4 months vs 6 months of XELOX chemotherapy for gastric cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING